ACCCBUZZ BLOG

Through a series of education projects, ACCC is committed to providing the resources the multidisciplinary cancer care team will need to navigate the complex precision medicine landscape and deliver next generation cancer care.

As immune checkpoint inhibitors have become the standard of care for eligible patients with NSCLC, frequent monitoring of irAEs as well as provider and patient education on the signs and symptoms of pneumonitis can ensure improved clinical outcomes for patients.

In the era of personalized medicine, biomarker testing is a tool the oncology workforce can and should leverage to deliver next generation cancer care.

Managing immunotherapy related adverse events (irAEs) requires a team-based effort, with pharmacists playing an integral role in their identification and management within both outpatient and inpatient multidisciplinary teams.

For patients with pancreatic cancer, clinical trials should be considered as a possible treatment option early on, not a last resort when all else fails. The Let's Win team discusses why.

Recognizing the effects of SDOH on patients and providers is key as studies show they can impact as much as 80% to 90% of health-related outcomes.

To explore the current state of psychosocial care in oncology, ACCC, with its partners, AOSW and APOS, with support from BeiGene—held a multistakeholder meeting, ACCC’s Call to Action: Delivery of Psychosocial Care in Oncology Summit.

In the past, patients diagnosed with rare cancer types often faced a bleak prognosis due to limited treatment options. Today, the story is different, as advances in precision medicine and the development of new, targeted therapies continue to permeate the oncology space.

In 2012, August 1 was declared World Lung Cancer Day—11 years later, its significance is as important as ever.

By implementing e-consults for patients experiencing endocrine immune-related adverse events, Duke Cancer Institute improved patient access and reduced healthcare utilization.

ACCC is working with multidisciplinary care teams to assess the impact of SDOH on equitable access to cancer care and clinical trials among minority populations.

The survival of pancreatic cancer is 12%, making it one of the deadliest cancers of our time. As a result, understanding the symptoms, risks factors, as well and the benefit of an early diagnosis is key.

In the face of an unprecedented drug shortage, Hematology/Oncology Pharmacy Association (HOPA) partnered with the Association of Community Cancer Centers (ACCC) and Association of VA Hematology/Oncology (AVAHO) to lead a virtual round table aimed at developing practical strategies healthcare organizations around the country can adopt.

ACCC set out to identify and understand specific regional challenges to appropriate and equitable care for patients with chronic lymphocytic leukemia, the most common form of leukemia in adults.

For National Pride Month this year, the Association of Community Cancer Centers (ACCC) is highlighting the transgender community and what it means for cancer programs and practices nationwide to provide trans-inclusive care.

The substantial strain placed on health care workers and organizations by unnecessary ED visits prompted Orlando Health Cancer Institute to develop their express symptom management program in July 2021. The program was designed to effectively triage and treat cancer related symptoms in the outpatient setting.

National Black Family Cancer Awareness Week is dedicated to raising awareness of the importance of clinical trial participation and specimen donations for cancer research among Black Americans.

Let’s Win Pancreatic Cancer is an advocacy organization that works with patients, providers, and researchers to share the latest information and treatment options for pancreatic cancer.

June is Cancer Immunotherapy Month, and ACCC is highlighting the important work that it and its partners are doing to increase patient access to these novel therapies.

ACCC recognizes National Cancer Survivors Day with stories from two survivors who are members of its staff.

ACCCBuzz spoke with Erika Siegrist at Luminis Health Research Institute to learn more about how technology has helped expand patient access to cancer clinical trials.

Telehealth can improve the experience of patients with cancer by facilitating access and reducing cost.

This May, ACCC is recognizing Bladder Cancer Awareness Month with a message highlighting the importance of awareness, patient education, and support.

As efforts to promote health equity continue to grow, educating patients with cancer about the importance of clinical trials and cancer screenings is of the utmost importance.